Medivel Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.80 M
- Paid Up Capital ₹ 0.80 M
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
- Satisfied Charges ₹ 1.00 M
- Revenue Growth 18.23%
- Profit Growth 76.49%
- Ebitda 2.79%
- Net Worth 51.52%
- Total Assets 3.29%
About Medivel Biotech
Medivel Biotech Private Limited (MBPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 October 2017 (Seven years and four months 8 days old ). Its registered office is in Kannur, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.80 M and a paid-up capital of Rs 0.80 M.
The company currently has active open charges totaling ₹1.00 M. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Abdul Salim, Dhananjayan Pallivalappil, Rajkumar Loganathan, and Three other members serve as directors at the Company.
Company Details
-
Location
Kannur, Kerala, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U33309KL2017PTC050670
-
Company No.
050670
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Oct 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Medivel Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Subramaniam
|
Managing Director | 10-Oct-2017 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Abdul Salim
|
Director | 10-Oct-2017 | Current |
|
Dhananjayan Pallivalappil
|
Director | 10-Oct-2017 | Current |
|
Rajkumar Loganathan
|
Director | 10-Oct-2017 | Current |
|
Radhakrishnan Mozhayanthodi
|
Director | 10-Oct-2017 | Current |
|
Vipindas Chandran
|
Director | 10-Oct-2017 | Current |
Financial Performance of Medivel Biotech.
Medivel Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.23% increase. The company also saw a substantial improvement in profitability, with a 76.49% increase in profit. The company's net worth Soared by an impressive increase of 51.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medivel Biotech?
In 2023, Medivel Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.00 M
₹1.00 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 May 2024 | Hdfc Bank Limited | ₹1.00 M | Open |
| 06 Dec 2018 | Bank Of India | ₹1.00 M | Satisfied |
How Many Employees Work at Medivel Biotech?
Unlock and access historical data on people associated with Medivel Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medivel Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medivel Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
